{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:53:43Z","timestamp":1781610823513,"version":"3.54.5"},"reference-count":0,"publisher":"Care Comm","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Onkol"],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.48095\/ccko2026195","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:16:06Z","timestamp":1781608566000},"page":"195-198","source":"Crossref","is-referenced-by-count":0,"title":["From progression to complete remission \u2013 a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma"],"prefix":"10.48095","volume":"39","author":[{"given":"Kate\u0159ina","family":"Bohu\u0148ovsk\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"28151","published-online":{"date-parts":[[2026,6,15]]},"container-title":["Klinicka onkologie"],"original-title":["Od progrese ke kompletn\u00ed remisi \u2013 kazuistika \u00fasp\u011b\u0161n\u00e9 l\u00e9\u010dby pemigatinibem u pacienta s metastazuj\u00edc\u00edm FGFR2+ cholangiokarcinomem"],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:16:07Z","timestamp":1781608567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.linkos.cz\/files\/klinicka-onkologie\/561\/6583.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,15]]},"published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.48095\/ccko2026195","relation":{},"ISSN":["0862-495X","1802-5307"],"issn-type":[{"value":"0862-495X","type":"print"},{"value":"1802-5307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}